Bioamber Commissions World's First Renewable Succinic Acid Plant
Bioamber, a joint venture between US-based DNP Green Technology andFrance-based ARD (Agro-industrie Recherches et Développements), announces the successful start-up and commissioning of the world's first bio-based succinic acid plant. Since December 2009, the plant has been producing renewable succinic acid from wheat derived glucose.
Built on time and on budget, this industrial scale plant has an initial annual capacity of 2,000 metric tons. Bioamber's renewable succinic acid offers higher purity than petroleum derived succinic acid, with the added benefit of consuming CO2 gas in the production process, giving it a distinct advantage over the traditional petrochemical route.
Bioamber will begin selling bio-based succinic acid immediately to a variety of customers and will build market demand as it negotiates the sale of licenses for large scale succinic acid plants.
Organizations
Other news from the department manufacturing

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Alzheimer Forschung Initiative e.V. - Düsseldorf, Germany

Use of low-energy electrons for innovative biotechnology processes

Researchers track down new biocatalysts - Microbiologists develop new phytase screening method
Targeted Genetics Corporation Proposes Combination with Biocontrol Limited
ArGEN-X and University of Bern enter into license agreement to develop ARGX-110-based combination therapies for treatment-resistant cancers
Novozymes and Ceres partner on biofuel crops - Companies take step towards commercialization of low-carbon biofuels from switchgrass and other energy crops
